Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. reduced its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 53.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,940 shares of the company’s stock after selling 16,897 shares during the quarter. Pacer Advisors [...]